| Ubiquilin-1 |
|---|
| Gene | genes/ubqln1|UBQLN1 |
| UniProt ID | Q9UMX0 |
| PDB Structures | 2JY5, 2KQX |
| Molecular Weight | ~63 kDa |
| Subcellular Localization | Cytoplasm, Nucleus, Endoplasmic Reticulum |
| Protein Family | Ubiquilin family |
Ubiquilin-1 (UBQLN1) is a member of the ubiquilin family of proteins that function as adaptors in the ubiquitin-proteasome system. It plays essential roles in protein quality control by delivering ubiquitinated substrates to the proteasome for degradation. UBQLN1 has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
UBQLN1 contains several functional domains:
- N-terminal Ubiquitin-like (Ubl) domain: Binds to proteasome 19S regulatory particle
- Central Sti1 domain: Mediates protein-protein interactions
- C-terminal Ubiquitin-associated (UBA) domain: Binds ubiquitin chains
The protein acts as a molecular shuttle, connecting ubiquitinated proteins to the degradation machinery.
UBQLN1 is central to cellular protein homeostasis:
- Proteasomal degradation: Targets misfolded proteins
- Autophagy regulation: Modulates selective autophagy
- ER-associated degradation (ERAD): Facilitates ER protein clearance
- Aggrephagy: Controls protein aggregate clearance
- Recognizes polyubiquitinated substrates
- Delivers cargo to 26S proteasome
- Coordinates ubiquitin chain editing
- Links different degradation pathways
- Amyloid precursor protein (APP): Regulates APP processing
- Tau degradation: May affect tau clearance
- Presenilin interaction: Affects gamma-secretase
- Autophagy-lysosome pathway: Dysregulation in AD
- UBQLN1 variants associated with AD risk
- Expression changes in AD brain
- Link to late-onset AD
- Autophagy modulation: Affects alpha-synuclein clearance
- Aggregate formation: UBQLN1 inclusions in PD brain
- PINK1/Parkin pathway: May intersect with mitophagy
- LRRK2 interactions: Possible pathway connections
- UBQLN1-positive inclusions
- Co-localization with synuclein
- Altered expression in substantia nigra
- Amyotrophic lateral sclerosis: Protein aggregate clearance
- Huntington's disease: Polyglutamine aggregate handling
- Frontotemporal dementia: Ubiquitin pathology
- Prion diseases: PrP clearance
UBQLN1 modulates proteasome function through:
- Substrate recognition
- Delivery to the 19S cap
- Regulation of proteasome activity
- Substrate recycling
- Modulates autophagy initiation
- Controls selective autophagy receptors
- Regulates aggrephagy
- Links to lysosomal pathway
- Facilitates ERAD pathway
- Responds to UPR
- Protects against ER stress
- Calcium homeostasis
- Proteostasis enhancers
- Autophagy inducers
- Small molecule stabilizers
- Ubiquitin modulators
- Wild-type UBQLN1 expression
- Allele-specific approaches
- CRISPR-based treatments
- Protein delivery
- UBQLN1 levels in CSF
- Blood-based markers
- Imaging correlates
- Knockout mice: Viable with accumulation
- Transgenic models: Neurodegeneration
- Cell models: Stress responses
- Patient-derived neurons
- Essential for protein quality control
- Protects against proteotoxic stress
- Links UPS and autophagy
- Disease-associated dysregulation